Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crump

Showing results (21-30 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell LymphomaAbi Vijenthira, John Kuruvilla, Michael Crump, et al.
British Journal of Haematology|October 3, 2002
Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphomaKevin W Song, Peter Mollee, Bruce Patterson, et al.
Cancer|January 28, 2003
Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysisLillian Sung, Rena Buckstein, John J Doyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials GroupMichael Crump, Dongsheng Tu, Lois Shepherd, et al.
Leukemia & Lymphoma|July 8, 2008
Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphomaJohn Kuruvilla, Melania Pintilie, Richard Tsang, et al.
Cancer|December 6, 2005
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphomaJohn Kuruvilla, Tracy Nagy, Melania Pintilie, et al.
American Journal of Hematology|September 28, 2010
Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literatureDavid Telio, Denis Bailey, Christine Chen, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 24, 2006
LymphomaChul S Ha, L Jeffrey Medeiros, Chusilp Charnsangavej, et al.
Journal of Pediatric Hematology/Oncology|April 4, 2012
Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girlRahul Naithani, Bo Y Ngan, Chaim Roifman, et al.
Journal of the National Cancer Institute|December 23, 2011
Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysisMurtadha Al Khabori, John R de Almeida, Gordon H Guyatt, et al.
Pageof 19

Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell LymphomaAbi Vijenthira, John Kuruvilla, Michael Crump, et al.
British Journal of Haematology|October 3, 2002
Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphomaKevin W Song, Peter Mollee, Bruce Patterson, et al.
Cancer|January 28, 2003
Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysisLillian Sung, Rena Buckstein, John J Doyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials GroupMichael Crump, Dongsheng Tu, Lois Shepherd, et al.
Leukemia & Lymphoma|July 8, 2008
Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphomaJohn Kuruvilla, Melania Pintilie, Richard Tsang, et al.
Cancer|December 6, 2005
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphomaJohn Kuruvilla, Tracy Nagy, Melania Pintilie, et al.
American Journal of Hematology|September 28, 2010
Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literatureDavid Telio, Denis Bailey, Christine Chen, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 24, 2006
LymphomaChul S Ha, L Jeffrey Medeiros, Chusilp Charnsangavej, et al.
Journal of Pediatric Hematology/Oncology|April 4, 2012
Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girlRahul Naithani, Bo Y Ngan, Chaim Roifman, et al.
Journal of the National Cancer Institute|December 23, 2011
Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysisMurtadha Al Khabori, John R de Almeida, Gordon H Guyatt, et al.
Pageof 19